The Role of SMAR1 in Breast Cancer
Author Information
Author(s): Kamini Singh, Devraj Mogare, Ramprasad Obula Giridharagopalan, Rajinikanth Gogiraju, Gopal Pande, Samit Chattopadhyay
Primary Institution: National Centre for Cell Science, Pune University, Pune, Maharastra, India
Hypothesis
SMAR1 plays a central role in coordinating p53 and TGFβ pathways in human breast cancer.
Conclusion
SMAR1 is downregulated in breast cancer, which is associated with increased Cyclin D1 expression and enhanced tumor cell migration and invasion.
Supporting Evidence
- SMAR1 expression is significantly reduced in malignant breast cancer tissues compared to benign cases.
- Downregulation of SMAR1 correlates with increased Cyclin D1 levels in breast cancer.
- SMAR1 inhibits tumor cell migration and metastasis through modulation of TGFβ signaling.
Takeaway
SMAR1 helps keep cancer cells from spreading by working with another protein called p53. When SMAR1 is low, cancer cells can grow and move more easily.
Methodology
The study analyzed SMAR1 expression in breast cancer samples and cell lines, using techniques like immunofluorescence, Western blotting, and luciferase assays.
Potential Biases
Potential bias in sample selection and the interpretation of results based on the specific cell lines used.
Limitations
The study primarily focused on in vitro and in vivo models, which may not fully replicate human breast cancer complexity.
Participant Demographics
The study included human breast cancer samples classified into benign and malignant categories.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website